
Vasafe-E Tablet
Marketer
Care Formulation Labs Pvt Ltd
Salt Composition
Atorvastatin (10mg) + Ezetimibe (10mg)
Overview Vasafe-E Tablet
Cholesto-Duo tablets effectively manage elevated cholesterol. This dual-action formulation lowers LDL ("bad") cholesterol and triglyceride levels. Cholesto-Duo may be taken with or without food, consistently at prescribed intervals to ensure efficacy. The dosage and treatment length are individualized. Complete the full course of treatment, even with symptom improvement. Lifestyle modifications—increased physical activity, smoking cessation, and a healthy, low-fat diet—enhance its effectiveness. Common, usually mild, side effects include nausea, abdominal discomfort, constipation, and myalgia. Report persistent or bothersome side effects. Immediately report jaundice, dark urine, or dark stools, potential indicators of liver injury. Regular blood sugar and liver function checks may be required. Inform your physician of pre-existing kidney disease, liver impairment, or hypertension before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Disclose all other medications to your healthcare provider due to potential interactions.
Primary Ingredients of Vasafe-E Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vasafe-E Tablet
Elevated serum cholesterol
Major Benefits of Vasafe-E Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vasafe-E Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Vasafe-E Tablet:
- Nausea
- Muscle pain
- Increased transaminase level in blood
- Upper respiratory tract infection
How to use Vasafe-E Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vasafe-E Tablets can be consumed with or without food, though consistent timing is recommended.
How Vasafe-E Tablet works:
Each Vasafe-E Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Vasafe-E Tablets.
PregnancyUNSAFE
Using Vasafe-E tablets during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in both animals and humans indicates substantial risks to fetal development.
Breast feedingCONSULT YOUR DOCTOR
The use of Vasafe-E Tablets while breastfeeding is likely inadvisable. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Vasafe-E Tablets might reduce awareness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Vasafe-E tablets without any required dosage modification.
LiverCAUTION
Patients with liver impairment should exercise caution when using Vasafe-E Tablets; dosage modifications may be necessary. Consult a physician before use. Vasafe-E Tablets are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Vasafe-E Tablet :
Should you forget a Vasafe-E Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vasafe-E Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
